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HYDROA VACCINIFORME TREATEI) WITH POTASSIUM
PARAAMINOBENZOATE*
C. J. D. ZARAFONETIS, M.D., A. C. CURTIS, M.D. AND J. M. SHAW, M.D.
Hydroa vacciniforme (1) is a rare, recurring vesicular disorder which involves only ex-
posed areas of the skin. Lesions are manifested in susceptible individuals following expo-
sure to sun and wind, so that avoidance of these elements usually prevents its appearance.
Once the lesions are present, however, treatment is generally symptomatic. Since para-
amino-benzoic acid therapy (2) has been employed in several clinical disorders associated
with ultraviolet sensitivity, it was reasoned that the compound might be beneficial in
hydroa vacciniforme. The present report describes improvement in a patient coincident
with potassium para-aminobenzoatef therapy.
Cese Report. J. H., a 9 year old boy, was admitted to the University of Michigan Pediatric
Ward on May 10, 1950. From early April to late September of the past 3 years, he had ex-
perienced a recurrent eruption on the exposed parts of the body. During the winter prior
to admission, however, the lesions did not disappear, hut instead became more profuse with
the coming of spring and increased exposure to sunlight. There was no family history of a
similar condition.
On examination, the patient was a red-haired, freckle-faced boy who did not appear to be
ill. A crusting, vesicular eruption of discrete lesions up to 1 cm. in diameter was present on
the nose and forehead, the lateral aspects of the face and neck, on the ears, and on the dorsa
of the hands. (Fig. 1). Some of the lesions appeared to be hemorrhagic.
Admission blood and urine studies were within normal limits. The Kahn test on the blood
serum was negative. Spectroscopic and qualitative tests for urinary porphyrins were nega-
tive. A skin test disclosed hypersensitivity to ultraviolet light exposure. The tuberculin
skin test was negative.
On May 11, 1950, potassium para-aminobenzoate (KPAB) administration was begun, 1
gm. every 3 hours, for 6 doses daily. By the fourth day of treatment, there was marked im-
provement of all lesions. He was discharged on lIay 20, 1950, completely free of the eruption
except for residual scarring. KPAB therapy (6 gm. daily) was continued at home, and the
patient returned 1 month later. No new lesions had appeared in the interim. Photographs
were taken for comparison with those obtained at the time treatment was instituted. (Fig.
2) KPAB was continued for 2 more weeks, and the patient remained free of lesions. There-
after, the patient received no further KPAI3. Correspondence with the subject's family
revealed that the eruption had again appeared some months later following exposure
to sunlight. Because of financial reasons, the patient could not be returned for additional
observation and therapy.
sUMMARy
A patient with classical features of hydroa vaeciniforme had rapid resolution of the erup-
tion during potassium para-aminobenzoate therapy. The subject remained free of lesions
throughout the 2 months period of therapy and for some time afterwards. Although hospi-
talization may also have been a factor, the relationship between KPAB therapy and the
prompt improvement observed in this case is suggestive. Unfortunately, no further oppor-
* From the Departments of Internal Medicine, University of Michigan and Temple
University Schools of Medicine, and the Department of Dermatology, University of Mich-
igan School of Medicine.
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f The potassium para-aminobenzoate ("Potaba") administered to this patient was
kindly supplied by the Glenwood Laboratories, Teaneck, New Jersey.
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FIG. 1. Appearance of patient at time KPAB therapy started
FIG. 2. Same areas after 6 weeks of treatment
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tunity to treat patients with this rare disorder has presented itself to us. Additional ex-
perience will, of course, be required before a definite opinion can he made regarding the ef-
fectiveness of potassium para-aminobenzoate in the treatment of hydroa vacciniforme.
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